Glucocorticoid (GC)-mediated down-regulation of urokinase plasminogen activator expression via the serum and GC regulated kinase-1/forkhead box O3a pathway

Endocrinology

Volumn 149, Issue 5, 2008, Pages 2637-2645

  Pew, Travis ^a   Zou, Min ^a   Brickley, Deanna R ^a   Conzen, Suzanne D ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD BOX PROTEIN O3A; FORKHEAD TRANSCRIPTION FACTOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; LUCIFERASE; MESSENGER RNA; UNCLASSIFIED DRUG; UROKINASE;

ARTICLE; BIOINFORMATICS; BREAST EPITHELIUM; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

BINDING SITES; BREAST NEOPLASMS; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; CONSERVED SEQUENCE; DEXAMETHASONE; DOWN-REGULATION; FORKHEAD TRANSCRIPTION FACTORS; GLUCOCORTICOIDS; HUMANS; IMMEDIATE-EARLY PROTEINS; MAMMARY GLANDS, HUMAN; MODELS, BIOLOGICAL; PROMOTER REGIONS (GENETICS); PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFECTION; URINARY PLASMINOGEN ACTIVATOR;

EID: 42449125705     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1096     Document Type: Article

References (40)

1. Franchimont D 2004 Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies. Ann NY Acad Sci 1024:124-137
2. Distelhorst CW 2002 Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ 9:6-19
3. Greenstein S, Ghias K, Krett NL, Rosen ST 2002 Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies. Clin Cancer Res 8:1681-1694
4. Moran TJ, Gray S, Mikosz CA, Conzen SD 2000 The glucocorticoid receptor mediates a survival signal in human mammary epithelial cells. Cancer Res 60:867-872
5. Mikosz CA, Brickley DR, Sharkey MS, Moran TW, Conzen SD 2001 Glucocorticoid receptor-mediated protection from apoptosis is associated with induction of the serine/threonine survival kinase gene, sgk-1. J Biol Chem 276:16649-16654
6. Runnebaum IB, Bruning A 2005 Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2. Clin Cancer Res 11:6325-6332
7. Amsterdam A, Tajima K, Sasson R 2002 Cell-specific regulation of apoptosis by glucocorticoids: implication to their anti-inflammatory action. Biochem Pharmacol 64:843-850
8. Eisen MB, Spellman PT, Brown PO, Botstein D 1998 Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868
9. Wu W, Zou M, Brickley DR, Pew T, Conzen SD 2006 Glucocorticoid receptor activation signals through forkhead transcription factor 3a in breast cancer cells. Mol Endocrinol 20:2304-2314
10. Webster MK, Goya L, Ge Y, Maiyar AC, Firestone GL 1993 Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol Cell Biol 13:2031-2040
11. Brunet A, Park J, Tran H, Hu LS, Hemmings BA, Greenberg ME 2001 Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol 21:952-965
12. Dano K, Behrendt N, Hoyer-Hansen G, Johnsen M, Lund LR, Ploug M, Romer J 2005 Plasminogen activation and cancer. Thromb Haemost 93:676-681
13. Andreasen PA, Kjoller L, Christensen L, Duffy MJ 1997 The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72:1-22
14. Busso N, Belin D, Failly-Crepin C, Vassalli JD 1986 Plasminogen activators and their inhibitors in a human mammary cell line (HBL-100). Modulation by glucocorticoids. J Biol Chem 261:9309-9315
15. Busso N, Belin D, Failly-Crepin C, Vassalli JD 1987 Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231. Cancer Res 47:364-370
16. Nerlov C, Rorth P, Blasi F, Johnsen M 1991 Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene 6:1583-1592
17. Beppu M, Ikebe T, Shirasuna K 2002 The inhibitory effects of immunosuppressive factors, dexamethasone and interleukin-4, on NF-κB-mediated protease production by oral cancer. Biochim Biophys Acta 1586:11-22
18. Kennedy SG, Wagner AJ, Conzen SD, Jordan J, Bellacosa A, Tsichlis PN, Hay N 1997 The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev 11:701-713
19. Wu W, Pew T, Zou M, Pang D, Conzen SD 2005 Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival. J Biol Chem 280:4117-4124
20. Johnson WE, Li W, Meyer CA, Gottardo R, Carroll JS, Brown M, Liu XS 2006 Model-based analysis of tiling-arrays for ChIP-chip. Proc Natl Acad Sci USA 103:12457-12462
21. Ji X, Li W, Song J, Wei L, Liu XS 2006 CEAS: cis-regulatory element annotation system. Nucleic Acids Res 34:W551-W554
22. Wu W, Chaudhuri S, Brickley DR, Pang D, Karrison T, Conzen SD 2004 Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res 64:1757-1764
23. Blais A, Dynlacht BD 2005 Constructing transcriptional regulatory networks. Genes Dev 19:1499-1511
24. Busso N, Collart M, Vassalli JD, Belin D 1987 Antagonist effect of RU 486 on transcription of glucocorticoid-regulated genes. Exp Cell Res 173:425-430
25. Augustine AJ, Oleksyszyn J 1997 Glucocorticosteroids inhibit degradation in bovine cartilage explants stimulated with concomitant plasminogen and interleukin-1 α. Inflamm Res 46:60-64
26. Ghaffari S, Jagani Z, Kitidis C, Lodish HF, Khosravi-Far R 2003 Cytokines and BCR-ABL mediate suppression of TRAIL-induced apoptosis through inhibition of forkhead FOXO3a transcription factor. Proc Natl Acad Sci USA 100:6523-6528
27. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME 1999 Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868
28. Crippa MP 2007 Urokinase-type plasminogen activator. Int J Biochem Cell Biol 39:690-694
29. Brommer EJ, Dooijewaard G, Dijkmans BA, Breedveld FC 1992 Plasminogen activators in synovial fluid and plasma from patients with arthritis. Ann Rheum Dis 51:965-968
30. Vitti G, Hamilton JA 1988 Modulation of urokinase-type plasminogen activator messenger RNA levels in human synovial fibroblasts by interleukin-1, retinoic acid, and a glucocorticoid. Arthritis Rheum 31:1046-1051
31. Hamilton JA, Hart PH, Leizer T, Vitti GF, Campbell IK 1991 Regulation of plasminogen activator activity in arthritic joints. J Rheumatol Suppl 27:106-109
32. Chen J, Yusuf I, Andersen HM, Fruman DA 2006 FOXO transcription factors cooperate with δ EF1 to activate growth suppressive genes in B lymphocytes. J Immunol 176:2711-2721
33. Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, Blalock WL, Franklin RA, McCubrey JA 2003 Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17:590-603
34. Pillay V, Dass CR, Choong PF 2007 The urokinase plasminogen activator receptor as a gene therapy target for cancer. Trends Biotechnol 25:33-39
35. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME 1999 Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868
36. Toker A, Yoeli-Lerner M 2006 Akt signaling and cancer: surviving but not moving on. Cancer Res 66:3963-3966
37. Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, Toker A 2005 Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell [Erratum (2006) 22:145] 20:539-550
38. Yiu GK, Toker A 2006 NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2. J Biol Chem 281:12210-12217
39. Hutchinson JN, Jin J, Cardiff RD, Woodgett JR, Muller WJ 2004 Activation of Akt-1 (PKB-α) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. Cancer Res 64:3171-3178
40. Irizarray RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP 2003 Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264